These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32458666)

  • 1. Post-discharge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: time for a change? Authors' reply.
    Niedziela JT; Strojek K; Gąsior M
    Kardiol Pol; 2020 May; 78(5):482-483. PubMed ID: 32458666
    [No Abstract]   [Full Text] [Related]  

  • 2. Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: time for a change?
    Patoulias D; Papadopoulos C; Toumpourleka M; Bakatselos S; Doumas M
    Kardiol Pol; 2020 May; 78(5):482-483. PubMed ID: 32458667
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence, characteristics, and prognostic implications of type 2 diabetes in patients with myocardial infarction: the Polish Registry of Acute Coronary Syndromes (PL‑ACS) annual 2018 report.
    Niedziela JT; Hiczkiewicz J; Kleinrok A; Pączek P; Leszek P; Lelonek M; Rozentryt P; Parma Z; Witkowski A; Bartuś S; Zdrojewski T; Buszman P; Kaźmierczak J; Strojek K; Gąsior M
    Kardiol Pol; 2020 Mar; 78(3):243-246. PubMed ID: 32063598
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.
    Lettino M; Andell P; Zeymer U; Widimsky P; Danchin N; Bardaji A; Barrabes JA; Cequier A; Claeys MJ; De Luca L; Dörler J; Erlinge D; Erne P; Goldstein P; Koul SM; Lemesle G; Lüscher TF; Matter CM; Montalescot G; Radovanovic D; Sendón JL; Tousek P; Weidinger F; Weston CFM; Zaman A; Li J; Jukema JW;
    Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):198-213. PubMed ID: 28329196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Avogaro A; Bonora E; Consoli A; Del Prato S; Genovese S; Giorgino F
    Diab Vasc Dis Res; 2019 Sep; 16(5):399-414. PubMed ID: 31044622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EXAMINE: targeting risk and treatment in diabetes - Authors' reply.
    White WB; Kupfer S; Zannad F
    Lancet; 2015 Oct; 386(10002):1445. PubMed ID: 26466044
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland.
    Gasior M; Gierlotka M; Pyka Ł; Zdrojewski T; Wojtyniak B; Chlebus K; Rozentryt P; Niedziela J; Jankowski P; Nessler J; Opolski G; Hoffman P; Jankowska E; Polonski L; Ponikowski P
    Eur J Prev Cardiol; 2018 Jun; 25(9):960-969. PubMed ID: 29692221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discharge heart rate and mortality after acute myocardial infarction.
    Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
    Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Sumitsuji S; Kawano S; Ueda Y; Hamasaki T; Sato H; Nanto S; Hori M; Komuro I;
    Circ J; 2013; 77(2):439-46. PubMed ID: 23075765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    Derosa G; Maffioli P
    N Engl J Med; 2016 Mar; 374(11):1095. PubMed ID: 26981947
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute coronary syndrome in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Aslandziia EN
    Ter Arkh; 2011; 83(9):66-70. PubMed ID: 22145391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
    Smáradóttir MI; Catrina SB; Brismar K; Norhammar A; Gyberg V; Mellbin LG
    Diab Vasc Dis Res; 2019 Jan; 16(1):22-27. PubMed ID: 30309264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
    Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA2DS2-VASc score.
    Lau YC; Lip GY
    Cardiol J; 2014; 21(5):451-3. PubMed ID: 25472850
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of intensive glycaemic control on ischaemic heart disease - Authors' reply.
    Gerstein HC; Miller ME
    Lancet; 2015 Mar; 385(9974):1180-1. PubMed ID: 25845790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.